Published: 18 January 2018
Author(s): Annika M.A. Berends, Edward Buitenwerf, Ronald R. de Krijger, Nic J.G.M. Veeger, Anouk N.A. van der Horst-Schrivers, Thera P. Links, Michiel N. Kerstens
Section: Original Article
Recent years have seen major changes in clinical practice which may have affected the incidence rates of pheochromocytoma(PCC)/sympathetic paraganglioma(sPGL). There is, however, a lack of up-to-date information describing trends in these incidence rates.